We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

97 hedge funds and large institutions have $348M invested in iShares US Pharmaceuticals ETF in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

26% more capital invested

Capital invested by funds: $276M → $348M (+$71.3M)

24.64% more ownership

Funds ownership: 120.84% → 145.48% (+25%)

5% more funds holding

Funds holding: 92 → 97 (+5)

26% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 35

Holders
97
Holders Change
+5
Holders Change %
+5.43%
% of All Funds
2.41%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
17
Increased
26
Reduced
35
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CI
Clal Insurance
Israel
+$66.8M
2
MTWSIF
Mivtachim The Workers Social Insurance Fund
Israel
+$5.69M
3
MIAN
Mariner Independent Advisor Network
Kansas
+$5.41M
4
TSS
Two Sigma Securities
New York
+$5.39M
5
CS
Credit Suisse
Switzerland
+$4.03M

Top Sellers

1
BWL
Bogart Wealth LLC
Virginia
-$12.4M
2
Bank of America
Bank of America
North Carolina
-$8.87M
3
Morgan Stanley
Morgan Stanley
New York
-$6.58M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$2.68M
5
TC
Telemus Capital
Michigan
-$2.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
CI
1
Clal Insurance
Israel
$137M +$66.8M +1,350,117 +99%
Bank of America
2
Bank of America
North Carolina
$25.1M -$8.87M -179,247 -26%
Morgan Stanley
3
Morgan Stanley
New York
$20.4M -$6.58M -132,999 -25%
PAG
4
Pinnacle Advisory Group
Maryland
$20.2M -$115K -2,322 -0.6%
AWA
5
ARS Wealth Advisors
Florida
$13.2M -$1.95M -39,339 -13%
Brown Advisory
6
Brown Advisory
Maryland
$9.79M -$773K -15,615 -7%
ST
7
Spinnaker Trust
Maine
$8.95M +$1.04K +21 +0%
Goldman Sachs
8
Goldman Sachs
New York
$8.51M -$146K -2,946 -2%
RTS
9
Round Table Services
New Jersey
$7.36M +$43.2K +873 +0.6%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$6.3M -$2.68M -54,228 -30%
Citadel Advisors
11
Citadel Advisors
Florida
$6.23M +$274K +5,529 +5%
MTWSIF
12
Mivtachim The Workers Social Insurance Fund
Israel
$5.78M +$5.69M +114,900 New
MIAN
13
Mariner Independent Advisor Network
Kansas
$5.5M +$5.41M +109,218 New
TSS
14
Two Sigma Securities
New York
$5.48M +$5.39M +108,912 New
Wells Fargo
15
Wells Fargo
California
$4.95M +$407K +8,217 +9%
Ameriprise
16
Ameriprise
Minnesota
$4.87M +$839K +16,947 +21%
MCM
17
Murphy Capital Management
New Jersey
$4.5M -$241K -4,875 -5%
CS
18
Credit Suisse
Switzerland
$4.39M +$4.03M +81,381 +1,387%
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
$3.45M +$151K +3,054 +5%
UBS Group
20
UBS Group
Switzerland
$3.45M -$596K -12,039 -15%
ACM
21
Avalon Capital Management
California
$3.44M +$3.38M +68,280 New
RJA
22
Raymond James & Associates
Florida
$3.15M +$551K +11,136 +22%
LPL Financial
23
LPL Financial
California
$3.04M -$478K -9,654 -14%
Jane Street
24
Jane Street
New York
$2.07M +$2.04M +41,136 New
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$1.67M +$996K +20,124 +155%
1
2 3 4 5

IHE Hedge Fund Activity: Q1 2017 in Review

97 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q1 2017, worth a combined $348M — up 26% from $276M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IHE positions and 11 closed out — a net gain of 6 holders — while 26 added to existing stakes and 35 trimmed.

The largest buyer was Clal Insurance, adding an estimated $66.8M. The largest seller was Bogart Wealth LLC, exiting entirely with an estimated $12.4M sold.

  • 97 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q1 2017, up from 92 in Q4 2016.
  • Funds reported $348M of iShares US Pharmaceuticals ETF stock for Q1 2017, up 26% quarter-over-quarter.
  • 17 funds opened new iShares US Pharmaceuticals ETF positions in Q1 2017 and 11 closed out, a net change of +6 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q1 2017 was Clal Insurance, an estimated $66.8M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q1 2017 was Bogart Wealth LLC, an estimated $12.4M sold.

Based on aggregated 13F filings for Q1 2017.